QR-koodi

Inflammation and increased intraocular pressure associated with intravitreal aflibercept 8 mg: A systematic review and meta-analysis

Topic: Aflibercept 8 mg was recently approved for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). The increased intravitreal injection volume and higher drug concentration has raised concerns regarding the potential risks of adverse events. The...

Täydet tiedot

Tallennettuna:
Päätekijät: Nikoline Skindhøj Rebsdorf, Marie Martine Michaelsen, Natasja Kærmose Ølholm, Suffía Olsen, Celine Lee, Yousif Subhi, Marie Ørskov, Henrik Vorum, Lasse Jørgensen Cehofski
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2025-12-01
Sarja:AJO International
Aiheet:
Neovascular age-related macular degeneration
nAMD
Aflibercept
Adverse event
Intraocular pressure
Intraocular inflammation
Linkit:http://www.sciencedirect.com/science/article/pii/S2950253525000838
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia